The Dark Report and DARK Daily Offer Free White Paper: A Guide to Effective Revenue Cycle and Compliance Management as Key Contributors to Increased Clinical Laboratory Profits and Valuation


21806 Briarcliff Dr.
Spicewood, TX 78669
512-264-7103 o
512-264-0969 f


Media Contact: Chris Garcia

AUSTIN, Texas (May 22, 2018) – The Dark Report and DARK Daily, leading sources of exclusive business intelligence for the laboratory and pathology industries, have released a FREE special edition White Paper focusing on the importance of a robust revenue cycle and compliance management system in today’s tumultuous clinical laboratory market.

This White Paper, entitled “The Laboratory Executive’s Guide to Maximizing Revenue & Valuation: Effective Revenue Cycle and Compliance Management are Critical Success Factors,” details the significance of a clinical lab or pathology group’s revenue cycle management capability in order to survive, and thrive, in a healthcare market that is more challenging than ever before.

As discussed in the White Paper, efficiency and effectiveness of a lab’s revenue cycle management (RCM) should be recognized as one of the fastest routes to financial improvement and successful navigation of the financial and regulatory challenges of today’s market.

“How well a lab manages RCM processes, workflows, and tools will determine its ability to capture all potential revenue and increase its profitability, and ultimately its valuation,” stated Robert L. Michel, Editor-in-Chief of The Dark Report. “This White Paper focuses on providing the reader with a thorough understanding of RCM and compliance best practices, thus enabling laboratory leaders to increase the profitability of their businesses.”

This White Paper will be an invaluable tool for any clinical laboratory or pathology practice interested in progressing their laboratory business to the next level. Highlights from the paper include:

  • Understanding the key metrics of lab profitability
  • RCM challenges in the lab, including workflow processes, compliance & fee schedules, and coding challenges
  • How to positively impact laboratory revenue through efficient revenue cycle management
  • What to look for when choosing a best-in-class RCM system for the lab organization

The overall goal of the White Paper is to provide a useful roadmap on how the most effective use of RCM can help labs collect more money, improve their cash flow, and dramatically increase both profits and valuation as their practices face the unprecedented operational, financial, and revenue challenges that will likely continue to grow as lab reimbursement and operating margins continue to shrink.

All interested practices and laboratory professionals can download this exclusive FREE White Paper, “The Laboratory Executive’s Guide to Maximizing Revenue & Valuation: Effective Revenue Cycle and Compliance Management are Critical Success Factors,” by clicking here. For additional information about the White Paper, The Dark Report, or DARK Daily, contact Chris Garcia at 512-264-7103. For information about XIFIN, visit


Established in 1995, THE DARK REPORT is the leading source of exclusive business intelligence for laboratory CEOs, COOs, CFOs, Pathologists and Senior industry executives. It is widely read by leaders in laboratory medicine and diagnostics. The Dark Report produces the famous Executive War College on Laboratory and Pathology Management every spring, which showcases innovations by the nation’s and globe’s leading laboratory organizations. Dark Daily is an Internet-based e-briefing intelligence service, read worldwide by thought leaders in laboratory and pathology management. Other well-known conferences conducted by THE DARK REPORT are Lab Quality Confab (on the use of Lean and Six Sigma methods in labs and hospitals) and Molecular Summit (on the integration of in vivo and in vitro diagnostics). THE DARK REPORT co-produces Frontiers in Laboratory Medicine annually in the United Kingdom; Executive Edge bi-annually in Canada; and The Business of Pathology bi-annually in Australia.